ABSTRACT: Methylation is a common and abundant posttranslational modification. High-throughput proteomic investigations have reported many methylation sites from complex mixtures of proteins. The lack of consistency between parallel studies, resulting from both false positives and missed identifications, suggests problems with both over-reporting and under-reporting methylation sites. However, isotope labeling can be used effectively to address the issue of falsepositives, and fractionation of proteins can increase the probability of identifying methylation sites in lower abundance. Here we have adapted heavy methyl SILAC to analyze fractions of the budding yeast Saccharomyces cerevisiae under respiratory conditions to allow for the production of mitochondria, an organelle whose proteins are often overlooked in larger methyl proteome studies. We have found 12 methylation sites on 11 mitochondrial proteins as well as an additional 14 methylation sites on 9 proteins that are nonmitochondrial. Of these methylation sites, 20 sites have not been previously reported. This study represents the first characterization of the yeast mitochondrial methyl proteome and the second proteomic investigation of global mitochondrial methylation to date in any organism.
■ INTRODUCTION
Often associated with the histone code, protein methylation is gaining recognition as a significant post-translational modification that can lead to enhanced function and regulation. 1 Much effort has been placed into identifying nonhistone protein substrates of methyltransferases, 2−5 especially in the baker's yeast, Saccharomyces cerevisiae, which has one of the most fully characterized methyltransferasomes. 6−9 A third of S. cerevisiae genes are orthologous to human genes, and half of the essential orthologous human genes exhibit functional complementarity in yeast. 10 Global methylation in yeast has been investigated through the use of high-throughput proteomics. 11−15 Because these studies have been performed with yeast grown in D-glucose, conditions where production of mitochondrial proteins is suppressed, mitochondrial methylation remains largely uncharacterized. Much of what is known about human mitochondrial defects has come from yeast studies. 16 Therefore, understanding the methylation of yeast mitochondrial proteins may increase our understanding for other eukaryotes.
The majority of protein methylation occurs on lysine and arginine residues. Known substrates for protein arginine and lysine methyltransferases are generally localized in the nucleus and cytoplasm 17−19 with significant methylation present in the cytoplasmic translational apparatus, 20 which contains some of the more abundant proteins in the cell. Hence, the majority of methylation sites being identified in large-scale protein modification studies via proteomics would be from these more abundant cellular compartments. Mitochondrial proteins may be in much lower abundance than their nuclear and cytoplasmic counterparts, 21 presenting a potential problem for proteomic studies of mitochondrial methylation.
Furthermore, less focus has been placed on the proteomic study of mitochondrial methylation. To date, there has only been one proteomic study of protein arginine methylation in the mitochondria, performed in Trypanosoma brucei. 22 Only two methylated mitochondrial proteins have been wellcharacterized in S. cerevisiae. Cytochrome c is trimethylated on a lysine residue by Ctm1 prior to import, 23 a modification that has been implicated in import, stability, protein−protein interactions, and apoptosis. 24−28 The mitochondrial translation release factor (Mrf1) is methylated by Mtq1 on a conserved glutamine residue, which is substoichiometric yet required for translation. 29 However, there are four putative protein methyltransferases 6−8 that are localized to the mitochondria but have unknown substrates: Rsm22, 30 Mtf1, 31 Oms1, 32 and Ykl162c. 33 This suggests that more mitochondrial protein substrates for methylation have yet to be identified.
A bottom-up approach to identify global mitochondrial protein methylation is desirable due to postimport processing of mitochondrial proteins 34 that complicates top-down methods. This approach is not without its drawbacks, especially when identifying methylation sites. There are two major issues with large-scale studies to detect methylation sites in proteins: a high false discovery rate and a low abundance of many methylated proteins. 35 Some of the artifactual methylation seen in large-scale studies that use Δ14 Da mass shift based identification to detect methyl groups is due to sample preparation or processing for mass spectrometry, especially for samples prepared in methanol and ethanol. 36−38 Many amino acid substitutions can result in changes of 14, 28, and 42 Da, so relying on mass shift alone could also incur misidentification of methylation on peptides. 39 Search algorithms can contribute to false-positives due to the misidentification of modifications as well. 40 Additionally, methylation may be substoichiometric or on low abundance proteins, making the sites difficult to detect in the background of more abundant species. 41 To make matters worse, low precursor ion abundances can lead to poor fragmentation. 35 As a result, there is often little to no overlap between the results of various yeast proteomics studies. 12, 14, 15 Thus, some previously reported methyl identifications may be artifactual, and many physiological methylation sites have likely escaped detection.
To overcome both of these problems, isotopic labeling coupled to analysis of purified subcellular fractions can be very useful. Heavy methyl stable isotope labeling by amino acids in cell culture (SILAC) can allow for unambiguous assignment of methylation to peptides. 39 This has been used with much success in human proteomic studies of methylation, 42−46 with improvements being made to the method, 47 but is less utilized in yeast. 15, 48 Recently, using heavy methyl SILAC in S. cerevisiae, Hart-Smith et al. 49 found that large-scale mass spectrometry identifications of methylation sites typically have high false discovery rates and emphasized the need for this type of methylpeptide validation. We have adapted heavy methyl SILAC for use with S. cerevisiae under respiratory conditions to allow for a full complement of mitochondria. Here we report the identification of 26 methylation sites, likely to be on lysine and arginine residues, in 20 proteins across three protein fractions, including 20 novel sites. This study presents the first characterization of the mitochondrial methyl proteome in yeast. Coupled to the results from previous proteomic studies, our work suggests that we may have only identified a fraction of biologically relevant modifications.
■ MATERIALS AND METHODS

Yeast Strains
Yeast wild-type BY4741 (MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0) and met6Δ (MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, met6::kanMX) strains were obtained from Open Biosystems (now GE Dharmacon).
Heavy Methyl SILAC
Cells were grown in 2 L of synthetic lactate media 50 modified for heavy methyl SILAC. Instead of yeast extract, 1.75 g/L yeast nitrogen base without amino acids or ammonium sulfate and 5 g/L ammonium sulfate was used. For light cultures, 0.79 g/L complete supplement mixture powder (CSM, MP Biomedicals) was added. For heavy cultures, CSM was omitted and the medium was supplemented with 0.75 g/L methionine dropout amino acid mix (CSM-Met, MP Biomedicals) and 20 mg/L Lmethionine (methyl-D 3 , 98%) (Cambridge Isotope Laboratories). Cells were grown in a shaker incubator at 30°C at 250 rpm to an optical density at 600 nm of ∼3 and harvested by centrifugation at 5000g for 5 min.
Protein Fractionation
Crude mitochondria were obtained as previously described 50 from each of the 2 L heavy and light cultures described above. Mitochondria were lysed using 1.3% Triton X-100 in 350 mM ammonium chloride, 20 mM magnesium acetate, 1 mM EDTA, 2 mM β-mercaptoethanol, 20 mM Tris-HCl, pH 7.5. The lysates (∼5 mL) were cleared by centrifugation at 30 000g for 10 min at 4°C, 51 and the protein concentration was determined by Lowry assay 52 after 10% trichloroacetic acid precipitation. For preparation of samples of crude mitochondria for mass spectrometry, equal amounts of protein from the light and heavy lysates were combined (500 μg each for a total of 1 mg of protein) and subjected to detergent removal and desalting using Pierce polyacrylamide spin desalting columns (7K MWCO) (Life Technologies). The desalted preparation was then precipitated with trichloroacetic acid as described. 53 Combined heavy and light mitochondrial lysates were stored at −20°C until preparation for mass spectrometry analysis.
A fraction of mitochondrial ribosomal proteins was prepared from the crude mitochondrial lysates described above. Lysates (4 mL) were centrifuged on top of a sucrose cushion (1 M sucrose, 0.1 M potassium chloride, 10 mM magnesium chloride, 0.1 mM EDTA, 1 mM dithiothreitol, 2 mM TES, pH 7.6) at 180 000g for 3 h 54 at 4°C with a Ti65 rotor (Beckman). The mitochondrial ribosomal proteins were acetic acid extracted, as previously described, 55 and protein concentrations were determined. Equal amounts of protein (5−10 μg each for a total of 10−20 μg of protein) from the light and heavy fractions were combined. Extracted proteins were dried using vacuum centrifugation and stored at −20°C until preparation for mass spectrometry analysis.
A third fraction was prepared from the supernatant of the initial mitochondrial pelleting described above. This largely cytosolic fraction was centrifuged at 159 000g for 2 h at 4°C with a Ti65 rotor (Beckman) to pellet ribosomes. The ribosomal proteins were acetic acid extracted, 55 and their protein concentration was determined. Equal amounts of heavy and light protein (100 μg each for a total of 200 μg of protein) were combined. Extracted proteins were dried in a vacuum centrifuge and stored at −20°C until preparation for mass spectrometry analysis.
Heavy methyl SILAC was performed in biological triplicate for cytoplasmic ribosomal proteins and mitochondria and biological duplicate for mitochondrial ribosomal proteins. Each biological replicate came from independently grown cultures.
followed by 10 mM iodoacetamide for 20 min at room temperature in the dark. The samples were then digested with Lys-C and trypsin proteases. First, Lys-C was added at an enzyme to substrate ratio of 1:100 and incubated for 4 h at 37°C
. Following Lys-C digestion, the samples were diluted to 2 M urea using 100 mM Tris, pH 8.5, CaCl 2 was added to a final concentration of 1 mM, and trypsin was added at an enzyme to substrate ratio of 1:50 for 12 h at 37°C. The trypsin digestion was stopped by the addition of formic acid at a final concentration of 5%. 56, 57 Samples were desalted using C18 tips according to the manufacturer's instructions, resuspended in 10 μL of 5% formic acid, and then analyzed by LC−MS/MS as described below.
Mass Spectrometry Analysis
The digested peptide mixture was desalted and concentrated using C18-packed pipet tips (Thermo Fisher) and fractionated online using a 75 μM inner diameter fritted fused silica capillary column with a 5 μM pulled electrospray tip and packed inhouse with 15 cm of Luna C18(2) 3 μM reversed-phase particles. An EASY-nLC 1000 ultra-high-pressure liquid chromatography (UHPLC) system (Thermo Fisher) was used to deliver the gradient, and MS/MS spectra were collected on a Q Exactive mass spectrometer (Thermo Fisher) as described. 58, 59 Data analysis was carried out using the ProLuCID and DTASelect2 implemented in the Integrated Proteomics Pipeline -IP2 (Integrated Proteomics Applications, San Diego, CA). 60 34 .0692 (dimethylation), and 51.1038 Da (trimethylation) on lysine or arginine. Database searches were conducted without enzyme specificity. Peptide identifications were filtered using DTASelect and required a unique fully tryptic peptide with a spectrum-level false-positive rate of 5%, as estimated by a decoy database strategy. 63 The Skyline software package was used to manually evaluate the presence of heavy-light peptide doublet from extracted ion chromatograms generated for each peptide. 64 For additional analysis to identify lysine, arginine, aspartate, or glutamate containing methyl peptides, a differential modification search was employed that considered variable mass shifts of 14.0157 (monomethylation), 28.0314 (dimethylation), and 42.0471 (trimethylation) on lysines, arginines, aspartates, or glutamates to identify unlabeled peptide. The heavy search considered a static mass shift of 3.0189 Da on methionine corresponding to L-[methyl-D 3 ]-methionine and variable mass shift of 17.0346 (monomethylation), 34 .0692 (dimethylation), and 51.1038 Da (trimethylation) on lysine, arginine, aspartate, or glutamate. Database searches were conducted without enzyme specificity using the MSGF+ search algorithm. 65 The search results were analyzed using Percolator and filtered at a spectrum-level q value of 0.01. 66 Methyl site localization and site probability was determined using the PTMRS algorithm. 67 The Skyline software package was used to manually evaluate the presence of heavy-light peptide doublet from extracted ion chromatograms generated for each peptide. 64 
Data Visualization and Structural Modeling
Sequence logos were generated using WebLogo. 68 Sequences of 10 amino acids N-terminal and C-terminal of the methylated residue were inputted. The Venn diagram comparing candidates in the three protein fractions was prepared using a Venn diagram webtool (Bioinformatics & Evolutionary Genomics, Ghent University). Structures were modeled using Protein Homology/analogy Recognition Engine V 2.0 (Phyre 2 ). 69 Structural figures of the Phyre 2 models were made using PyMol (Schrodinger).
Comparison using UniProt Database
Data obtained from this study and others like it were compared using proportional Venn diagrams. Proportional Venn diagrams were made from these methylated protein lists from cited studies using BioVenn. 70 The curated list from the Universal Protein Resource (UniProt) Database 71 used for these comparisons was made as follows. The list was generated by first going to "keywords" in UniProt. From here, the category of Post-Translational Modification was selected, and methylation specifically was chosen from the keywords navigation. Only "Reviewed" proteins were mapped to the keyword. The reviewed methylation keyword results were then filtered by organism (Saccharomyces cerevisiae (strain ATCC 204508/ S288c) (Baker's yeast)). This data set, once downloaded, comprised the "UniProt 2015" protein list. These comparisons are based on the open reading frame and not on the methylation site.
■ RESULTS
Labeling of Yeast Strains with L-[methyl-D 3 ]-methionine
To detect methylated yeast mitochondrial proteins, we first attempted a large-scale study of mitochondrial fractions from wild type and methyltransferase knockout strains using MudPIT 72 without any isotopic labeling. This approach yielded many methylated peptide hits, but we were concerned that we did not consistently observe such peptides in various strains, leading us to question whether some or many of the hits could be false-positives. We then optimized a heavy methyl SILAC protocol for labeling methyl groups in yeast proteins with methyl-deuterium-labeled methionine. This method has been used with much success for unambiguously determining methylated peptides in a variety of human cell lines. 39,42−46 Yeast take up exogenous methionine rapidly 73 and convert it into S-adenosyl-L-methionine (AdoMet), 74 which is then used as the primary methyl donor by methyltransferases in the cell. Other methyl donors include O 6 -methylguanine of DNA (used by Mgt1), 75 5,10-methylenetetrahydrafolate (used by Cdc21), 76 and N
5
-methyltetrahydrofolate (used by Met6). 77 To optimize such labeling, it is important to shut down endogenous methionine biosynthesis that can dilute the label. The yeast wild-type BY4741 strain is already a methionine auxotroph with a deficiency in the MET15 gene (also known as MET17, MET25), encoding the enzyme forming the homocysteine precursor of methionine. 78 We first utilized this strain for heavy labeling with L-[methyl-D 3 ]-methionine. With heavy labeling alone, we found incomplete and inconsistent levels of incorporation in different peptides (Figure 1 ), resulting in variable levels of light methylation being present in the heavy-labeled culture. Because of the importance of having a 1:1 ratio of heavy and light proteins for the analysis of the peptides, the dilution of the label was problematic. If only the light form of the methylated peptide is present in the heavy culture (e.g., no label incorporation), then it will not be identified as methylated as there will be no heavy-light doublet in the MS1 spectra, only a light peak for that peptide from both the heavy and light cultures. It is likely here that unlabeled methyl groups can be introduced in the MET15 deletion strain via the Met6 methionine synthase from N 5 -methyltetrahydrofolate. 77, 79 The MET6 gene deletion strain has a mild phenotype aside from methionine auxotrophy. 80 We have observed that met6Δ cells grew similarly to BY4741 cells in synthetic nonfermentable medium, allowing for mitochondrial fractionation. We thus utilized a strain containing a MET6 deletion mutation that prevents the methylation of homocysteine to methionine. 77 The use of this strain resulted in increased efficiency in labeling ( Figure 1 ).
The met6Δ cells were thus grown in both light and heavy media under respiratory conditions and harvested; then, extracts were separated into three protein fractions: mitochondria, mitochondrial ribosomal proteins, and cytoplasmic ribosomal proteins, as described in the Materials and Methods. The latter fraction was prepared as a positive control because the methylation status of these proteins has been well established. 2 The resulting heavy and light protein fractions were combined in a 1:1 ratio for mass spectrometric analysis. A total of three independent cell-labeling experiments were done; three independently prepared fractions of the mitochondria and of the cytoplasmic ribosomes and two independently prepared fractions of mitochondrial ribosomal proteins were digested with a trypsin/Lys-C protease mixture and analyzed by mass spectrometry as described in the Materials and Methods.
Identification of Peptides Containing Methylated Residues
To analyze the collected peptide mass spectral data for methylated peptides, two ProLuCID searches were set up for each protein fraction replicate in the IP2 platform, as described in the Materials and Methods. Both were closed searches for methylation of lysine (mono-, di-, and tri-) and arginine (mono-, and di-) specifically. One differential modification search considered only "light" peptides: peptides with a variable mass shift of 14.0157 (monomethylation), 28 .0314 (dimethylation), and 42.0471 (trimethylation) Da. The other differential modification search considered "heavy" peptides: peptides with a static mass shift of 3.0189 Da (from L-[methyl-D 3 ]-methionine) and variable mass shifts of 17.0346 (monomethylation), 34.0692 (dimethylation), and 51.1038 Da (trimethylation). We also performed additional searches to include the detection of methylated aspartate and glutamate residues, as described in the Materials and Methods. The peptide lists from these searches were then exported into Skyline libraries for evaluation of the presence of the expected heavy-light doublet in the extracted precursor ion chromatograms generated from each identified light/heavy methylated peptide pair. An example of this is seen in Figure 2A . We confirmed the heavy-light doublet by matching the observed isotope distribution of each precursor ion with the theoretical distribution ( Figure 2B ). Novel methylated peptides were further evaluated based on their presence in multiple replicates and the quality of their MS/MS spectra generated by HCD fragmentation.
From the data in all eight mass spectrometric analyses (two or three replicates from each of the three protein fractions), 112 peptides were identified using IP2 and Skyline as having a mass shift consistent with methylation but did not show the expected light/heavy doublet (an example is shown in Figure 2C ,D; peptides are listed in Table S-1, tab 2). However, we did identify 36 peptides from 20 proteins in these experiments that displayed the expected light/heavy doublet (Table S-1, tab 3). Thus only 25% of peptides identified as methylated by the ProLuCID search algorithm were validated using heavy methyl SILAC. In rare cases, AdoMet is not used as a methyl donor. 75, 76 However, it appears that many of these identifications may be false-positives. Our results suggest that studies that do not validate methylated peptide identifications using heavy methyl SILAC or other quantifiable methods may overestimate the number of methylation sites occurring in the cell, potentially reporting methylation sites that are not present.
Here we report 26 methylation sites on 20 proteins across the three protein fractions. There was little overlap between methylated candidates in the three protein fractions, as seen in Figure 3 . Of the proteins that overlapped, two were highly abundant, Ssa2 and Ssa4, which are part of the Hsp70 family of proteins, and two that are known to be methylated as well as abundant, Tef1/2 (eEF1A) and Rpl42ab. These results indicate that discrete pools of methylated proteins exist in the cytoplasm and the mitochondria.
Validation of Approach by Analysis of the Cytoplasmic Ribosomal Fraction
The cytoplasmic ribosomal protein fraction was used as a reference set for the heavy methyl SILAC method (Table 1) . We validated four sites on three ribosomal proteins: dimethyl K106 and K110 on Rpl23ab, 81 monomethyl K55 on Rpl42ab, 82 and monomethyl R67 on Rpl12ab, 83 as seen in Table 1 . The following lysine and arginine methylations on ribosomal proteins were not found in our analysis: trimethyl K3 on Rpl42ab, 82 monomethyl K46 on Rpl1, 84 monomethyl K40 on Rpl42ab, 82 mono-or dimethyl R11 on Rps2, 85 and monomethyl R145 on Rps3. 85 It is unclear if these sites were missed due to incomplete sampling of precursor ions during our data-dependent acquisition method or due to the absence of the modification under respiratory rather than fermentative growth conditions. It would be intriguing if these sites were required for function under fermentation but not under Figure 1 . Improved enrichment of the deuterated methionine label into proteins of S. cerevisiae strains with a deletion in the MET6 gene encoding the cobalamin-independent methionine synthase. As described in the Materials and Methods, wild type (WT) and met6Δ strains were heavy-labeled, mitochondrial ribosomal proteins were isolated, digested with trypsin/Lys-C and analyzed by LC−MS/MS. For each peptide identified, the ratio of the areas of the extracted ion chromatograms for each labeled and unlabeled peptide pair was calculated to obtain a fractional enrichment of
respiratory conditions. It is also possible that the trimethyl K3 site on Rpl12ab may have been missed because it would be found in a peptide with a modified dimethylproline residue at position 1, 86 which was not considered during the database search. Arginine methylation at position 11 of Rps2 is substoichiometric, 87 which may be why this modification was missed. We also identified previously unseen methylation variants of Rpl23ab, including trimethylation and monomethylation at K106 and K110. These forms are distinct from the well-characterized dimethyl K106/dimethyl K110 species (Table 1, Figure S-1, Figure S-2) . However, such methylation site assignments were based primarily on the presence of a single site-determining ion and may represent sites that are mislocalized by the search algorithm.
We also found a number of ribosome-associated methylated proteins in this fraction. Eukaryotic elongation factor 1A (eEF1A), encoded by TEF1/TEF2, is known to be highly methylated on five lysine residues: monomethyl K30, trimethyl K79, dimethyl K316, monomethyl K390, and a C-terminal lysine methyl ester. 88, 89 Our approach here identified three out of the five sites, as seen in Figure 4 : monomethyl K30, trimethyl K79, and monomethyl K390, the latter of which may be substoichiometric and at lower occupancy than the other methylated lysines on eEF1A. 90 We also identified a peptide containing the potentially novel monomethylation of K30 and K35. On the basis of the fragmentation pattern for this peptide ( Figure S-1) , however, this methylation site assignment could be incorrect as the site-determining ions support dimethylation of K30 as well. The other elongation factor methylation sites, trimethyl K509 and dimethyl K613 on EF2 and trimethyl K187, K196, and K789 on EF3, 91 were not identified; again, it is unclear whether these sites are not methylated under respiratory conditions or were simply missed in the analysis. We also detected methylation on the Ded1 RNA helicase required for translation initiation for yeast mRNA. 92 Here we confirm the dimethyl R51 site previously found. 93 Finally, we were able to detect methylation sites on several other proteins. We were able to confirm the dimethylation of abundant histone H3 protein (Hht1) at K37 94 that may have contaminated the cytoplasmic ribosome preparation. We additionally find a potentially novel monomethyl K38 on histone H3 (Figure S-1) . K38 methylation is supported by two diagnostic site-determining ions, so further investigation is needed. Importantly, novel methylation sites are identified as follows: monomethyl K422 on Ssa4, monomethyl K421 on Ssa2, and dimethyl R89 on Hsp26. Ssa4, Ssa2, and Hsp26 are all cytoplasmic heat-shock-induced chaperones 95 ,96 that poten- tially copurified with cytoplasmic ribosomal proteins through interaction with nascent polypeptide chains.
As described above and in the Materials and Methods, known methylation sites were validated with additional analyses for lysine, arginine, glutamate, and aspartate methylation, with the exception of Rpl23ab, where the first dimethylation event has an even probability of being on K106 or E108 (Table 1) . Additionally, although the majority of peptides gave unambiguous assignment of the trimethyl to K79 via site probability, a portion of the peptides did have equal site probability between K79 and E81. As this methylation is well characterized, 88 we can determine that the trimethylation occurs on K79.
Many of the novel methylated peptides were not identified in the additional analysis, including Rpl23ab, histone H3, eEF1a, and Ssa2/4. Hsp26, containing a C-terminal dimethyl arginine on R89, has a region of likely dimethylation, spanning from D64 to D77. On the basis of a spectrum to spectrum comparison between the two searches, the likely residues containing the methylation due to probability are D74 and D76, as they share an equal probability. Because dimethyl aspartate is highly unlikely, the methylation possibly occurs on R66.
Analysis of the Mitochondrial Ribosomal Fraction
In the mitochondrial ribosomal protein fraction, three mitochondrial ribosomal proteins were identified as methylated: Mnp1, Mrpl4, and Mrpl40 (Table 2, Figure 5 , Figure S -2). Like their cytoplasmic counterparts, mitochondrial ribosomal proteins are also subject to this modification. Mnp1, Mrpl40, and Mrpl4 are all large subunit components. 97 Methylation of mitochondrial ribosomal protein L11 has been reported in Arabidopsis thaliana; 98 we find no evidence of the methylation of the corresponding yeast protein in our study. A number of methylation sites of mitochondrial ribosomal proteins were also reported in Trypanosoma brucei, 22 but confirmatory isotope labeling was not used in that study. The T. brucei homologue of Mnp1, Tb927.7.4550, was found to be methylated on an arginine residue in that study.
The novel methylation sites found in the mitochondrial ribosomal protein fraction are monomethyl R55 on Pdb1, monomethyl K144 on Pst2, monomethyl K558 on Ecm10, The presence of methylated histone H3 is a possible sign of nuclear contamination. There was expected cytoplasmic ribosomal protein contamination in the mitochondrial ribosomal protein fraction, as demonstrated by the presence of methylated peptides from Rpl23ab, eEF1A, Rpl12ab, Rpl42ab, and a novel methylation on Rps2 (Table 2) . Analyzing the data for aspartate and glutamate methylation in addition to lysine and arginine methylation yielded additional confirmation of known sites in this fraction, with the exception of methyl peptides from eEF1a and Rpl23ab. Although alternative and novel methylation states are identified with opening up the search for D/E methylation (Table 2) , the known methyl peptide containing dimethyl K106 and dimethyl K110 on Rpl23ab was no longer identified. The peptide identified corresponded better to the novel trimethyl K106 and monomethyl K110 peptide, although it was found in the scan number for the dimethyl K106 and K110 peptide. The methyl peptide containing monomethyl K30 had equal probability for the monomethylation to occur on a nearby aspartate (D35). However, as mentioned previously, given the well-studied nature of eEF1a lysine modifications, it is more likely that the methylated residue truly is K30. 88 Additionally, the novel methylation of histone H3 on K38 appears to be more likely on the known residue of K37.
While the methyl peptides were not identified for any of the three MRPs, a shortened methyl peptide that did not contain K56 had a high probability of methylation on E68 on Mnp1. Similarly, the methyl peptide containing R260 on Lat1 was not identified, while the peptide containing K340 had equal probability of the dimethyl on K340 or D343. The methylation of Pdb1 cannot be clearly assigned to R55 in this fraction but spans a region from E51 to D58. For the corresponding peptides from the previous search, it appears to be an equal probability of methylation on either E51 or E52. Neither of the exact matching novel methyl peptides of trimethyl/monomethyl K106 and monomethyl/trimethyl K110 on Rpl23ab were identified. Similar peptides yielded methyl site probabilities that indicated possibility of E108 methylation. There is stronger basis for trimethyl K106 and monomethyl K110 based on probability. However, within this search, all methylations were initially misassigned to E96 and D97.
Clear site assignments occurred for the methyl peptides of Ssa2/4, Pst2, Ecm10, and Rps2. While the original site assignment for Ssa2/4 was K421/422, the additional analysis gave this methyl peptide a high probability for methylation on E423/E424. Similarly, Pst2 monomethylation has a high probability on E121 instead of K144. Ecm10 monomethylation likely occurs on K558 having been identified in the search for just K/R and in K/R/D/E with a high probability for that residue. The same is true for monomethylation of Rps2 at K49, which is a new modification for the ribosomal protein that could be required for the ribosome under respiratory conditions.
Analysis of Methylated Proteins in the Mitochondrial Fraction
The majority of candidate methyl peptides identified were mitochondrial in origin, as seen in Table 3 ( Figure S-3) . The newly identified sites in this protein fraction were as follows: monomethyl R55 on Pdb1, trimethyl K308 on Ald5, monomethyl K422 on Ssa4, monomethyl K421 on Ssa2, trimethyl K490 on Hsp60, trimethyl K345 on Ald4, and dimethyl K360 on Aco1. None of these have been previously identified. Methylated peptides from both Rpl42ab and eEF1A were also identified, likely due to the abundance of these proteins.
In additional database searches for methyl lysine, arginine, glutamate, and aspartate, these methylpeptides were confirmed, albeit putatively on alternative sites (Table 3) . It is apparent from the fragmentation pattern of the methyl peptide containing the monomethyl arginine on Pdb1 as well as the methyl site probabilities that the methylation cannot be localized. Here we are confident given results from the MRP fraction that the peptide contains a methylation mark; however, it cannot be assigned to R55 but is confined to the methylatable residues from E51 to D58 as in the MRP fraction. On the contrary, the trimethylation of K308 on the methylpeptide from Ald5 appears to be correctly assigned based on methyl site probabilities. This occurred for K490 on Hsp60 as well. The potential methylations of Ssa2/4 and Aco1 present an interesting divergence from the previous search algorithm. The monomethylation on Ssa2/4 was assigned to E423/4 with high probability, as opposed to K421/422. The dimethyl on Aco1 was not able to be localized based on probability. Although the exact corresponding peptide from the original search was not identified, similar peptides contained equal probability on the methylatable residues from D323 to E345. It is clear that two methyl groups are present on this peptide, whether as one dimethyl lysine or two monomethylations as dimethyl D or E is not biologically possible.
Clear assignments were seen for known sites of monomethyl K55 on Rpl42ab and monomethyl K30 on eEF1a with high methyl site probabilities. This is to be expected as (1) these Figure 5 . Novel methylated peptides found in mitochondrial ribosomal protein fraction. Extracted precursor ion chromatograms for light (top) and heavy (bottom) peptides containing (A) dimethyl K56 on Mnp1, (B) monomethyl R204 on Mrpl4, and (C) monomethyl K186 on Mrpl40. The zero, +1, and +2 isotopes are shown in blue, magenta, and red, respectively. The methylated residue is highlighted in blue in the peptide sequence. Fragmentation patterns of product ions for (D) Mnp1, (E) Mrpl4, and (F) Mrpl40 methyl peptides. Methylated residue is highlighted in yellow in the peptide sequence. methylation events are unambiguously on lysine residues and (2) these methyl peptides contain few, if any, acidic residues for assignment. The assignment of trimethyl 79 on eEF1a in the methyl peptide was less clear. While the exact matching peptide from the original search carried unambiguous probability for trimethylation solely on K79, in most of the methyl peptides identified in the K/R/D/E search, the methyl site probability split for localization to either K79 or E81. However, Ssa2 is largely cytoplasmic and nuclear, but has been found to localize to the mitochondria as well. 21, 99 Whether the methylation of K422/E424 or K421/E423 is on Ssa2, Ssa4, or both proteins is unclear, as it is in a conserved region of the proteins, and the resulting peptide is identical, as seen in Figure  6 . As Ssa2 potentially localizes to the mitochondria, the presence of Ssa2 and Ssa4 in this fraction could be due to that localization. This might also suggest that the methylation is on Ssa2. However, both Ssa2 and Ssa4 may also represent some cytoplasmic or ribosomal contamination, as they were found in that fraction as well. Additionally, the arginine monomethylation site determined in humans (HsR669, ScR466/7) 100 was not found in this or any fraction.
Sequence Specificity of Methylation
While this study focused primarily arginine and lysine methylation, it is possible that other methylation sites exist on other residues such as histidine, glutamine, or asparagine, 101−103 although these are much less common than arginine and lysine. However, on the basis of the original analysis of these data, it appears that lysine methylation could be more prevalent in protein fractions examined, as seen in Table 1 . This could be due to the fact that this study sought to determine global mitochondrial methylation, whereas the substrates for arginine methyltransferases (Rmt1, Rmt2, Sfm1, and Hsl7) in yeast are localized in the cytoplasm and nucleus. 104 Additionally, there does not appear to be any sequence specificity for lysine ( Figure 7A ,B) or arginine ( Figure  7C ) methylated residues determined in this study. Again, the common arginine methylation motif (RGG), which Rmt1 is known to methylate 105 is not seen, except in the known Rmt1 substrate, Ded1, presumably because no other methylated arginine site is an Rmt1 target. Thus structural elements appear to be required for the modification at these sites in place of or in addition to the amino acid sequence adjacent to the methylatable residue. On the basis of structural models, most of the newly identified methylation sites are surface-exposed in structurally accessible regions of the proteins (Table S-1, Table  1 , Figure S-4) . Surface-exposed residues are more likely to be accessible as substrates for a methyltransferase.
■ DISCUSSION Approach
Our study presents the first look at global protein methylation in the mitochondria of Saccharomyces cerevisiae through the use of heavy methyl SILAC. This work identifies potential substrates for the mitochondrially localized candidate protein methyltransferases. Our finding that mitochondrial ribosomal proteins specifically are methylated is consistent not only with reports of methylated mitochondrial ribosomal proteins from trypanosomes and Arabidopsis but also as a hallmark modification for ribosomal proteins as a whole. 20 Identification of these methylation reactions may offer insight into the functional and regulatory detail of mitochondrial translation, metabolism, control, and dynamics.
Many other proteomic studies have attempted to characterize the methyl proteome of S. cerevisiae. Even with validation techniques, such as isotopic labeling, there is little to no overlap between methylated proteins determined from established methyl proteome studies and those curated from Uniprot ( Figure 8 , Table S-2) . It thus appears that the methylation sites identified in any given study represent only a fraction of the methylation that occurs on the cellular level. The lack of overlap with the study presented here is likely also due to our focus on analyzing mitochondrial fractions rather than the entire proteome.
Opening searches up to methyl E and D resulted in more E and D assignments than K/R. Many may not be biologically relevant, for example, trimethyl E81, as opposed to trimethyl K79 on eEF1a, which is a known and well-characterized modification. However, many monomethylation events on glutamate or aspartate appear to be possible as on Pdb1 or Ssa2/4. There are few examples of acidic residue methylation in S. cerevisiae. Pab1 in yeast and other organisms has been reported to be methylated on various glutamate residues needed for function. 106 There have been whole cell investigations of glutamate and aspartate methylation in yeast. However, these experiments performed were dependent on ingel digests, and it is unclear if methanol was avoided in sample preparation. 103 Additionally, the only well-characterized example of an acidic residue methyltransferase is CheR in the prokaryote chemotaxis signaling system. 107 This does not have a homolog in yeast. Although there are many putative methyltransferase with substrates that have yet to be identified, 9 there currently is no identified glutamate or aspartate methyltransferase in yeast. While possible, it seems unlikely that newly identified sites are indeed localized on D/E residues, unless acidic residue methyl esterification may be more common in the mitochondria. Until all of the methyltransferases in yeast have been characterized, this remains a possibility.
Mitochondrial Methylation
Methylated mitochondrial protein candidates serve a variety of functions. Mitochondrial fraction candidates are involved in metabolism or mitochondrial genome maintenance in some capacity. Both Ald4 and Ald5 are mitochondrial aldehyde dehydrogenases. Constitutively expressed Ald5 is the minor isoform, while Ald4 is the major isoform. 108 Pdb1 is the E1 beta subunit of pyruvate dehydrogenase. 109 Ald4 and Pdb1, along with candidates Hsp60 and Aco1, are mitochondrial nucleoid proteins, suggesting a role of methylation in the maintenance of the mitochondrial genome. 110, 111 Interestingly, of these, the aconitase Aco1 112 is a multifunctional protein that acts not only in the TCA cycle but also in mtDNA maintenance in an enzyme activity-independent manner. Previous studies suggest that Aco1 couples metabolism to mitochondrial genome maintenance. 110, 113 Although Aco1 is known to be phosphorylated, 114−116 it is unclear how this modulates Aco1 function. Coupled now to Aco1 methylation, further work is needed to understand how its many post-translational modifications affect its functions.
Methylation may certainly affect translation, similar to the cytoplasmic translational apparatus. Mnp1 and Mrpl4 have essential functions in mitochondrial translation. 97, 117, 118 Additionally, Mnp1, the L7/12 homologue 119 on the yeast mitochondrial ribosome, is vital not only for mitochondrial translation but also for cell cycle progression as well. 120 Gene deletion of Mnp1 not only affects respiratory growth but also is lethal under fermentative conditions. Methylation of these proteins could represent a point of regulation of mitochondrial translation or be important for assembly or function, as is the case for cytoplasmic ribosomal proteins. 101, 121 Although not a mitochondrial ribosomal protein, Lat1, the E2 component of the pyruvate dehydrogenase complex, 122 was recently found to associate with mitochondrial ribosomes. 123 Our finding of methylated Lat1 peptides in the MRP fraction suggests that Lat1 does indeed interact with the mitochondrial ribosomes. Other potentially mitochondrial ribosome associated proteins were Pdb1, also the E1 beta subunit of pyruvate dehydrogenase, 109 Ecm10, one of the mitochondrial Hsp70s, 124 and Pst2, a protein of unknown function found in mitochondrial proteome studies. 125 Like Lat1, Ecm10 and Pdb1 may also interact with mitochondrial ribosomes, which may explain their presence in this fraction. Both Ecm10 and Pdb1 localize to mitochondrial nucleoids. 110, 126 It has been recently discovered that mitochondrial ribosomes form complexes at mitochondrial nucleoids, termed MIOREX complexes. 123 The presence of Ecm10, Pdb1, and Lat1 in the MRP fraction may be indicative of these MIOREX complexes.
Chaperone Methylation and the "Chaperone Code"
Many molecular chaperone proteins were identified as methylated in this study, including Hsp60 and Ssa2/4. Hsp60 is the major chaperone in the mitochondria. In humans, HSPD1, the Hsp60 homologue, interacts with both ETFBKMT and METTL21B. 127 ETFBKMT and METTL21B are lysine methyltransferases; this interaction could facilitate a methylation reaction with HSPD1 as a substrate. There are no known interactions of Hsp60 with methyltransferases in yeast.
Methylation of Ssa2/4 is unexpected as the methylation did not occur on the conserved methylation site that was previously reported for Hsp70 proteins in human cells. 127−130 Methylation of Hsp70 proteins in humans has been implicated as part of a "chaperone code", 131 and enhanced methylation is often seen in cancer. 130 However, this site, K556 in Ssa2 and K559 in Ssa4, has been reported as unmethylated in yeast. 90 We also did not find evidence of lysine 556/559 methylation under respiratory conditions. Monomethylation of K421 or K422 under respiratory conditions presents a unique departure from their human counterparts, particularly if this site is truly on E423 or E424. Monomethylation on lysine 421/422 or E423/424 is novel and presents a divergence from the known methylation state in human Hsps. As the conserved methylation has been implicated in human malignancies, 130 a further study is required to determine whether this novel methylation site affects Hsp70 function as well.
■ CONCLUSIONS
Importantly, we were able to adapt heavy methyl SILAC for use in commercially available met6Δ strain of yeast. While we have found that methyl proteome studies that do not use isotope labeling have the propensity to overestimate biologically relevant methylations, current heavy methyl SILAC studies using the MET6 + BY4741 strain 15, 48 likely underestimate the methylations reported. This is due to the fact that Met6 can catalyze the formation of light methionine using N 5 -methyltetrahydrofolate. Gene deletion of MET6 ensures that heavy cultures will contain only heavy methylated proteins. It is our hope that with this knowledge heavy methyl SILAC can be more widely used in the yeast methyl proteome community. 
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